Clinical Research Associate - Bio Equivalance require in Macleods | 2 openings
 Macleods has its presence in over 30 countries with more than 300 registrations.
Macleods has its presence in over 30 countries with more than 300 registrations.The export range of Macleods are manufactured in a unit that has QSM approval from WHO-Geneva, and certifications from various International Regulatory Authorities like - USFDA, MCC, UKMHRA, MOH – Belarus, INVIMA – Colombia, National Drugs Authority - Uganda, Food and Drugs Board - Ghana, MCAZ – Zimbabwe, Pharmacy and Poisons Board Kenya, Pharmacy Board Tanzania etc.
  Post: Clinical Research Associate - Bio Equivalance 
Job Description:
- Study co- ordination
- Plasma separation
- Custodian role
- ICF (Inform consent form) presentation
- Study co- ordination
- Plasma separation
- Custodian role
- ICF (Inform consent form) presentation
  Candidate Profile:
- Candidates having 1 - 3 yrs of experience in Bio clinical dept
- With qualification of M.pharm(pharmacology) or M.Sc (Clinical research)
- Candidates having 1 - 3 yrs of experience in Bio clinical dept
- With qualification of M.pharm(pharmacology) or M.Sc (Clinical research)
  Other Information:
Experience: 1-2 years
Education: M.Pharm, M.Sc
Location: Mumbai
Industry Type: Pharma/ Biotech/Clinical Research
Functional Area: CR
Experience: 1-2 years
Education: M.Pharm, M.Sc
Location: Mumbai
Industry Type: Pharma/ Biotech/Clinical Research
Functional Area: CR
  Candidate may mail their resume at, rndhrd@macleodspharma.com
 
 
 Syngene  International is one of India’s premier contract research and  manufacturing organizations in providing customized service. Our  services encompasses all across discovery chain: early stage discovery,  process development, cGMP manufacturing and formulation development both  in the small molecule and novel biologics area. Based in Bangalore,  Karnataka, the Company is situated in a 90 acre Special Economic Zone  with over 100000 sq. mt of built up facilities. The state-of-the-art  research facilities have been qualified by various pharmaceutical majors  & regulatory agencies and has received various certifications  including ISO 9001: 2008, ISO 14001:2004, OHSAS 18001:2007, GLP and  AAALAC.
Syngene  International is one of India’s premier contract research and  manufacturing organizations in providing customized service. Our  services encompasses all across discovery chain: early stage discovery,  process development, cGMP manufacturing and formulation development both  in the small molecule and novel biologics area. Based in Bangalore,  Karnataka, the Company is situated in a 90 acre Special Economic Zone  with over 100000 sq. mt of built up facilities. The state-of-the-art  research facilities have been qualified by various pharmaceutical majors  & regulatory agencies and has received various certifications  including ISO 9001: 2008, ISO 14001:2004, OHSAS 18001:2007, GLP and  AAALAC.
.jpg)








 In  the FDA regulated environment, it is not acceptable for programmers or  their managers to deviate from standardized methodologies. Given the  type of software commonly found in FDA regulated operations, the  criticality and complexity of computer systems, the evolving regulatory  climate, and the current industry best practices, validating computer  systems can be problematic. Covering regulatory requirements stipulated  by FDA and GAMP guidelines, 21 CFR 11: Complete Guide toInternational  Computer Validation Compliance for the Pharmaceutical Industry  delineates the organization, planning, verification, and documentation  activities and procedural controls required for compliance. Whether you  need to validate computer systems for pharmaceutical cosmetic, food, or  medical devise applications, this book is indispensable. Discussing the  regulatory requirements that are the foundation for any project, the  book introduces a model that can be used to determine the Part 11  requirements for consideration during implementation. The book  establishes a top-down approach to the integration of computer systems  validation strategies in support of a computer systems validation  project. It focuses on practical issues in computer systems  implementation and operational life project management, including  relevant activities to comply with Part 11, validation planning, and  scheduling. The book reviews documentation in relation to CSV and  procedural controls in regulated operations. The book shows how to  enable compliance with computer systems validation requirements while  highlighting and integrating Part 11 requirements into the entire  computer validation program. The author places regulatory compliance  within the context of quality assurance and emphasizes the importance of  integrating validation into the system lifecycle using a structured  top-down approach. This systematic approach helps you efficiently  develop compliant software and maintenance its compliance
In  the FDA regulated environment, it is not acceptable for programmers or  their managers to deviate from standardized methodologies. Given the  type of software commonly found in FDA regulated operations, the  criticality and complexity of computer systems, the evolving regulatory  climate, and the current industry best practices, validating computer  systems can be problematic. Covering regulatory requirements stipulated  by FDA and GAMP guidelines, 21 CFR 11: Complete Guide toInternational  Computer Validation Compliance for the Pharmaceutical Industry  delineates the organization, planning, verification, and documentation  activities and procedural controls required for compliance. Whether you  need to validate computer systems for pharmaceutical cosmetic, food, or  medical devise applications, this book is indispensable. Discussing the  regulatory requirements that are the foundation for any project, the  book introduces a model that can be used to determine the Part 11  requirements for consideration during implementation. The book  establishes a top-down approach to the integration of computer systems  validation strategies in support of a computer systems validation  project. It focuses on practical issues in computer systems  implementation and operational life project management, including  relevant activities to comply with Part 11, validation planning, and  scheduling. The book reviews documentation in relation to CSV and  procedural controls in regulated operations. The book shows how to  enable compliance with computer systems validation requirements while  highlighting and integrating Part 11 requirements into the entire  computer validation program. The author places regulatory compliance  within the context of quality assurance and emphasizes the importance of  integrating validation into the system lifecycle using a structured  top-down approach. This systematic approach helps you efficiently  develop compliant software and maintenance its compliance Written by top authorities in process validation, this reference  explores current trends in the field and strategies for selecting the  most appropriate quality control scheme. It offers practical guidelines,  recommendations, and an abundance of case studies that showcase various  techniques and approaches in the validation of biopharmaceutical  processes. These include guidance on determining the life spans of  chromatography and filtration media, process characterization and  techniques for scaling-down unit operations in biopharmaceutical  manufacturing, examples of contamination events, and practical methods  for testing raw materials and in-process samples during various  manufacturing stages.
Written by top authorities in process validation, this reference  explores current trends in the field and strategies for selecting the  most appropriate quality control scheme. It offers practical guidelines,  recommendations, and an abundance of case studies that showcase various  techniques and approaches in the validation of biopharmaceutical  processes. These include guidance on determining the life spans of  chromatography and filtration media, process characterization and  techniques for scaling-down unit operations in biopharmaceutical  manufacturing, examples of contamination events, and practical methods  for testing raw materials and in-process samples during various  manufacturing stages.
 This work presents a comprehensive contemporary framework for approaching target validation in drug  discovery. It begins with a detailed description of new enabling  technologies, including aptamers, RNA interference, functional genomics,  and proteomics. The next section looks at biologic drug development  with in-depth discussion of lessonslearned from such well-known cases as  Erbitux, Herceptin, and Avastin. Additional targets known as "second  generation" drugs, which can be identified when disease pathways are  validated by biologics, present new possible small molecule therapeutics  and serve as the focus of the final section of the book
This work presents a comprehensive contemporary framework for approaching target validation in drug  discovery. It begins with a detailed description of new enabling  technologies, including aptamers, RNA interference, functional genomics,  and proteomics. The next section looks at biologic drug development  with in-depth discussion of lessonslearned from such well-known cases as  Erbitux, Herceptin, and Avastin. Additional targets known as "second  generation" drugs, which can be identified when disease pathways are  validated by biologics, present new possible small molecule therapeutics  and serve as the focus of the final section of the book








